Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announced encouraging results in two preliminary ...

Less than a quarter of adults and around 13% of children have gotten a COVID-19 vaccination this past season, CDC data shows, ...

GeoVax was using its HHS contract to develop its next-generation multi-antigen COVID-19 vaccine, which is in Phase IIb ...

The COVID-19 vaccine continues to save lives, proving the vaccination strategy paid off and was a worthwhile national ...

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...

Abu Dhabi, brings together key partners including PureHealth’s Rafed, AD Ports Group’s Khalifa Economic Zones Abu Dhabi (KEZAD), Abu ...

For meningococcal vaccines, ACIP recommended that GSK's pentavalent vaccine (Penmenvy), designed to protect against A, B, C, ...

The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including the COVID-19 vaccine for 2025-2026.

A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...